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Enalapril reduces collagen type IV synthesis and expansion of the
interstitium in the obstructed rat kidney. Chronic unilateral ureteral
obstruction (UUO) results in interstitial fibrosis of the affected kidney.
In this study we determined that enalapril ameliorates the increased
production of extracellular matrix (ECM) protein in the tubulointersti-
tium during UUO. The relative volume (Vv) of the tubulointerstitium
measured by a point-counting method increased significantly at three or
five days of UUO as compared to the contralateral kidney. Enalapril
significantly blunted this increase at either three or five days. Immuno-
fluorescence studies revealed that collagen type IV increased remark-
ably in both the tubular basement membrane (TBM) and the interstitial
space at three or five days of UUO. Glomeruli did not show any change.
Collagen types land III were faintly stained in the control kidneys while
they were obviously increased in the interstitial space of the obstructed
kidney. We examined the expression of collagen type IV (COL IV)
because this basement membrane matrix protein appeared to be a major
ECM protein deposited in the tubulointerstitium of the obstructed
kidney. Semiquantitative analysis of COL IV by immunofluorescence
microscopy revealed that enalapril reduced slightly (2 1%) but signifi-
cantly (P < 0.01) the deposition of COL IV in the obstructed kidney.
Measurement of cyanogen bromide peptides from the obstructed kid-
ney by Western blotting showed an increase of COL IV. This increase
was reduced slightly (20%) by enalapril. The level of COL IV mRNA
measured by reverse transcription-PCR was very low or undetectable in
the control and contralateral kidneys, while it was significantly in-
creased in the obstructed kidney at three or five days of UUO. COL IV
mRNA was abundant in glomeruli while it was almost undetectable in
renal tubules in the control and contralateral kidneys. However, COL
IV mRNA was increased in renal tubules but not in the glomeruli of the
obstructed kidney. Enalapril treatment resulted in a 42% decrease (P <
0.01) in COL IV mRNA in the cortex and a remarkable decrease in the
renal tubules of the obstructed kidney at five days. Enalapril treatment
resulted in an 89% decrease in the number of infiltrating ED-i positive
monocytes/macrophages. These results indicate that enalapril treat-
ment ameliorates the tubulointerstitial fibrosis of the affected kidney in
UUO. This effect of enalapril on fibrosis may be due to the severe
reduction in monocytes/macrophages capable of secreting the profi-
brotic factor TGF-j3l.
Chronic ureteral obstruction causes tubulointerstitial fibrosis
of the kidney. Nagel and Bulger [1] showed that in the rabbit
with unilateral ureteral obstruction (UUO) collagen fibers and
fibroblasts were increased in the interstitium of the affected
kidney at seven days post-obstruction. Sharma et al [2] reported
increased kidney synthesis of various ECM components (col-
lagen types I, III and IV, fibronectin and heparan sulfate
proteoglycan) in the interstitium of rabbits with ureteral ob-
struction of three and seven days duration. These data suggest
that renal interstitial fibrosis may begin promptly after the onset
of obstruction.
TGF-j3 is a major cytokine in the regulation of production and
deposition of ECM proteins [3, 4]. TGF-f3 regulates gene
transcription of collagen types I, III, and IV, fibronectin and
laminin [5—7]. We found increased mRNA expression of
TGF-pl in the cortex of the obstructed kidney when compared
to the contralateral kidney of rats as early as three days after
UUO was initiated [8]. The administration of enalapril, an
angiotensin I converting enzyme inhibitor (ACEI), significantly
blunted but did not completely abrogate the increased expres-
sion of TGF-/31 mRNA present in the renal cortex at five days
of UUO [8]. Enalapril reduces glomerular injury in rats with a
remnant kidney [9.-.11]. Enalapril also ameliorates interstitial
fibrosis of rats with cyclosporine nephrosis [12], aminonucleo-
side nephrosis [13] or subtotal nephrectomy [14]. These data
suggest that enalapril may have a role in suppressing the
increased synthesis of ECM proteins during renal injury al-
though its mechanisms have not been elucidated.
In the present study we focused on the expression of mRNA
and protein synthesis of COL IV. This basement membrane
matrix protein appeared to be a major component of tubuloin-
terstitial fibrosis during UUO. The previously noted reduction
in TGF-/31 mRNA expression due to enalapril treatment [8] was
explored by determining the effect of ACEI on monocyte/
macrophage infiltration of the UUO kidney. Thus, the aims of
this study were to assess mRNA expression of COL IV and its
deposition in the tubulointerstitium and to determine whether
enalapril ameliorates the increased synthesis of COL IV in the
tubulointerstitium of the affected kidney in UUO.
Methods
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Experimental protocol
Female Sprague-Dawley rats, weighing 200 to 240 g, were
used. Under fluothane anesthesia the left ureter was ligated
with 4-0 silk at two points and cut between the ligatures in order
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Fig. 1. Criteria for matrix deposition score for COL IV by immunofluorescence. Matrix deposition score is determined to be: 0, no changes
(control or contralateral kidney); 1, mild change; 2, moderate change; and 3: severe change. Magnification: x400.
to prevent retrograde urinary tract infection. Sham-operated
rats had their ureters manipulated but not ligated. Rats were
sacrificed at three or five days of UUO under pentobarbital
anesthesia (50 mg/kg body weight, i.p.). Sham-operated rats
and unoperated rats were used to obtain "control" kidneys.
Enalapril (5 mg/kg body weight) (Sigma, St. Louis, Missouri,
USA), an ACEI, was administered intraperitoneally at 24
hours, 12 hours and one hour before surgery and every 12 hours
alter surgery for three or five days, at which point the animals
were sacrificed. Sham-operated rats were similarly treated and
sacrificed at three or five days after surgery.
Tissue preparation
Rats were anesthetized with pentobarbital. For histological
studies kidneys were perfused in vivo with phosphate buffered
saline (PBS), pH 7.2, to clear blood-borne cells and then with
4% paraformaldehyde in PBS, pH 7.2, for 10 minutes. In some
rats Histochoice (Amresco, Solon, Ohio, USA) was substituted
for paraformaldehyde. The kidneys were removed quickly and
sliced longitudinally in 2 mm thick sections, further immersed in
the same fixative for four hours at 4°C, washed with PBS and
embedded in paraffin. Paraffin sections, 4 .tm in thickness, were
subjected to Azan-Mallory stain or indirect immunofluores-
cence stain.
For RNA extraction rat kidneys were perfused in situ with
cold Hanks' balanced salt solution (HBSS), removed quickly
and placed in cold HBSS. The cortex was immediately dis-
sected from the kidney and stored at —70°C. Glomeruli and
tubules were isolated by a sieve technique (mesh size: 250, 150
and 75 m) and stored at —70°C.
Immunofluorescence stu4ies
The deparafiunized sections were washed in 0.05 M Tris-HC1
buffer, pH 7.6, and treated with 0.1% trypsin type I (Sigma) in
0.1% CaC12 and 0.05 M Tris-HCI, pH 7.6 for 30 minutes at room
temperature. Sections were washed in PBS for 10 minutes three
times, preincubated in blocking solution (10% goat or rabbit
serum in PBS) for 30 minutes, washed in PBS three times and
then incubated with primary antibody in PBS for two hours at
room temperature. Goat polyclonal antibody against type IV
collagen (1:40 dilution) (Fisher, Pittsburgh, Pennsylvania,
USA), or rabbit polyclonal antibodies against type III (1:40) and
type 1(1:20) collagen (Chemicon, Temecula, California, USA)
were used as primary antibodies. The serum of animals in which
the primary antibody was developed was used as a negative
control. Each section was washed three times in PBS and
incubated with a second antibody (1:80 dilution) in PBS for 30
minutes. Fluorescein isothiocyanate (FITC)-conjugated rabbit
anti-goat IgG or goat anti-rabbit IgG (Sigma) was used as a
second antibody. After washing with PBS three times, the
section was mounted with Fluoromount-G (Fisher, Pittsburgh,
Pennsylvania, USA).
Semiquantitative analysis of COL IV by immunofluorescence
microscopy
The deposition of COL IV in the tubulointerstitium of renal
cortex was assessed semiquantitatively by fluorescence micros-
copy. The matrix deposition score from 0 to 3 was based on the
intensity and distribution of COL IV in the tubulointerstitium:
0, no changes; 1, mild change; 2, moderate change; and 3,
severe change (Fig. 1). In each section the matrix score was
counted randomly in over 100 fields under high power (x400).
Observers did not know whether histologic sections being
examined were from control rats or rats with UUO.
Morphometric analysis of the interstitial volume
A standard point counting method was used to quantitate the
volume of the renal interstitium [15]. The relative volume (Vv)
of the interstitium of the cortex was determined on the sections
stained using the Azan-Mallory method to stain collagen fibers
in tubular basement membrane (TBM), glomeruli and intersti-
tial space. Under high magnification (x400) consecutive non-
overlapping fields were photographed from each section of
renal cortex. A grid containing 117 (13 x 9) sampling points was
superimposed on each photograph and a total of 1,404 to 2,691
points were evaluated in -each kidney. The number of points
overlying TBMs and interstitial space were counted while
points falling on Bowman's capsule or peritubular capillaries
were not. Points falling on glomerular structures or on larger
vessels were excluded from the total count.
Immunoblotting for COL IV
SDS-PAGE was performed to quantitate the production of
collagen proteins. Collagen fibers in the cortex were cleaved
with cyanogen bromide (CNBr) [16, 17]. Renal cortical tissue
which had been perfused with HBSS and stored at —70°C was
incubated in 70% formic acid at 37°C overnight in screw-cap
tubes. CNBr (Sigma) dissolved in 70% formic acid was added to
each sample. The sample was flushed with nitrogen to remove
oxygen and incubated for four hours at 37°C. The specimen was
centrifuged at 35,000 x g for 30 minutes and the supernatant
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passed over a column of P6 gel (50 to 100 mesh, Bio-Rad,
Richmond, California, USA) (column buffer: 1 M acetic acid) to
separate peptides from the formic acid and CNBr. CNBr
peptides were lyophilized. The lyophilized protein was dis-
solved in distilled water, centrifuged briefly and the supernatant
processed for immunoblotting. CNBr peptides were electropho-
resed through a 13.5% polyacrylamide gel (30% acrylamide/
0.4% Bis-acrylamide) containing SDS and transferred to a
nitrocellulose membrane (Trans-Blot Transfer Medium, Bio-
Rad) at 100 volts for 60 minutes. The membranes were blocked
and exposed to goat polyclonal antibody against COL IV
(Fisher) at 1:200 dilution for one hour. Rabbit anti-goat IgG
conjugated to alkaline phosphatase (Sigma) was used as a
second antibody at a 1:10,000 dilution.
RNA extraction
Total RNA was extracted from the renal cortex, glomeruli
and tubules using the guanidinium isothiocyanate (RNAz01)
method (Cinna/Bioteck, Houston, Texas, USA) [18]. The total
RNA was dissolved in TE buffer (10 mrs Tris, 1 mri EDTA) and
quantitated by UV spectrophotometry at 260 nm and 280 nm.
RNA with an 0D260/0D280 ratio over 1.9 was used for cDNA
synthesis.
Characterization and quan:1cation of collagen a(IV) mRNA
by RT-PCR
First-strand cDNA was synthesized with a cDNA cycle kit
from Invitrogen (San Diego, California, USA), using 4 g of
total RNA and priming with oligo dT. The mixture of total RNA
and oligo dT primer was incubated at 65°C for two minutes to
denature the secondary strand and chilled on ice. The resulting
mixture was incubated at 42°C for one hour, heated to 94°C for
three minutes and chilled on ice. A second round of reverse
transcription was performed after adding 5 units of avian
myeloblastosis virus (AMY) enzyme.
Polymerase chain reaction (PCR) coupled to reverse tran-
scription of RNA (RT-PCR) was carried out. Three microliters
of each cDNA were amplified to a total volume of 50 .d
containing PCR buffer (50 m KCI, 10 m Tris-HC1), 1.5 mM
MgC12, 200 M of each dNTP, 100 pmol of oligonucleotide
primers for COL IV or 12.5 pmol of GAPDH primers and 1.25
units of Taq DNA polymerase (Promega, Madison, Wisconsin,
USA). In order to quantitate PCR products comparatively and
confirm the integrity of the RNAs we coamplified a house-
keeping gene, glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) in a companion tube. We used a small amount (0.5
.tl) of cDNA from the cortex to amplify the GAPDH message to
prevent the PCR product of GAPDH from reaching a plateau at
higher cycles of amplification. The sequences of primers for
collagen al(IV) mRNA were designed from the sequence of the
mouse gene: (sense) S'-GTGCGGrfTGTGAAGCACCG, (anti-
sense) 3'-GUCTFCTCATGCACACTT (363 bp) [19]. The
GAPDH primers were designed from the rat gene: (sense)
5-AATGCATCCTGCACCACCAA, (anti-sense) 3 '-GTAGC-
CATATFCATTGTCATA (515 bp) [20]. PCR was carried out
with a Perkin Elmer Cetus DNA Thermal Cycler using the
following program: 94°C for one minute (denaturing), 54°C for
one minute (annealing) and 72°C for two minutes (extension).
Amplification was carried out at 45 cycles for the cDNA of
cortex and at 40 cycles for the cDNAs of glomeruli and tubules.
PCR products were sequenced using the TA Cloning System
(Invitrogen) and the AmpliTaq Sequence kit (Perkin Elmer,
Norwalk, Connecticut, USA). The resultant sequences (not
shown) confirm the identity of the PCR products as collagen
al(IV) and GAPDH.
PCR products were quantitatively analyzed as described
previously [8]. After amplification, 15 .tl of each PCR reaction
mix was electrophoresed through a 1.2% agarose gel with
ethidium bromide (0.5 .tgIml). The gel was photographed with
Polaroid Type 665 positive/negative film (Polariod Corporation,
Cambridge, Massachusetts) over UV light at the same exposure
and developing time. The bands on the negative film were
scanned by densitometry (Sepra Scan 2001 software, Integrated
Separations System, Natwick, Massachusetts, USA) for quan-
tification. The PCR products for collagen al(IV) or GAPDH
amplified from the same cDNA were electrophoresed in the
same gel and the ratio of collagen al(IV)/GAPDH was deter-
mined to eliminate gel-to-gel or film-to-film variance.
Identification and quantitation of infiltrating
monocytes/macrophages
Histochoice-fixed paraffin embedded sections were used.
Monocytes/macrophages were identified using antibody ED- 1
(Harlan Bioproducts for Science, Inc., Indianapolis, Indiana,
USA) using techniques previously described [21]. The primary
antibody was located with an alkaline phosphatase-linked goat
antimouse IgG (Sigma) and Fast Red color development. He-
matoxylin was used as the counterstain. The number of ED-l
positive cells was determined in three randomly chosen 400x
fields within the same section of renal cortex from an individual
animal and averaged. The average number of ED-i positive
cells from three separate animals was calculated.
Blood pressure measurement
Measurements were obtained as previously described [221.
Briefly, rats were lightly anesthetized with halothane. An
indwelling PE-50 catheter was placed into the left femoral
artery. After 30 minutes for recovery from anesthesia and
surgery, three successive readings were obtained. Mean arterial
pressure (MAP) was determined continuously through the left
femoral artery catheter connected to an electronic transducer
(Weco VT-i, Winston Electronics, Millbrae, California, USA).
Statistical analysis
Data, shown as mean SD, were analyzed by the unpaired
t-test. An unpaired t-test with Welch's correction was used to
analyze the data on the relative volume of the renal interstitium
and blood pressure. ANOVA was employed to determine the
significance of the ED- 1 cell infiltrate into the renal cortex.
Results
Morphology of the renal cortex during UUO
Figure 2 demonstrates sections of renal cortex stained with
Azan-Mallory stain. In the control kidney collagen fibers were
observed in the TBM, Bowman's capsule, and mesangium and
around the intertubular capillaries. The peritubular interstitial
space was usually very narrow. Slightly wider spaces were also
seen, characterized by interstitial cells and small amounts of
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Fig. 2. Photographs of renal cortex stained with Azan-Mallory. Control kidney (A) and obstructed kidneys at 3 days (B) and 5 days (C) after UUO
are shown. The contralateral kidney showed no difference from the control kidney on both days. Magnification: x400.
Fig. 3. Volume fraction (Vv) of the tubulointerstitium with or without
enalapril treatment during UUO. Abbreviations are: C, contralateral
kidney; 0, obstructed kidney; UNTR, untreated; ENL, enalapril. At 3
days N = 4 for untreated animals and N = 3 for enalapril-treated
animals. At 5 days N = 5 for each group. The bar represents mean
SD. * P < 0.01; ** P < 0.05 versus contralateral kidneys.
collagen fibers (Fig. 2A). On the third day of UUO the affected
kidney showed an obviously widened interstitial space with a
greater number of interstitial cells and infiltrating leukocytes
(Fig. 2B). Collagen fibers were increased in the interstitial
space, forming a fine network. Thickening of the TBM was
beginning in some renal tubules but this was a minor change at
three days. At five days collagen fibers were further increased
in the interstitial space. The TBM was thickened in the area
where interstitial inflammation was more prominent (Fig. 2C).
These changes were observed in the whole cortex at five days
although the degree of severity was not homogeneously distrib-
uted. In contrast, there were no changes in collagen deposition
in the glomeruli of either the contralateral or obstructed kidney
at three or five days.
Morphometric analysis of interstitial volume
The relative volume of the interstitium was expressed by the
volume fraction (Vv) (Fig. 3). Vv of the contralateral kidney
was approximately 10% (same as that of the control kidney) and
did not change with enalapnl administration. The interstitial
volume of the obstructed kidney was significantly (P < 0.01)
increased at three days or five days as compared to that of the
contralateral kidneys. Enalapril administration blunted the in-
crease in the interstitial volume significantly (P < 0.01), from
25% to 14% at three days and from 28% to 20% at five days,
although the interstitial volume of the enalapril-treated rats was
still significantly greater than that of the contralateral kidney,
which averaged 10 to 12%.
Immunofluorescence studies on COL I, COL III and COL IV
proteins
In the control and contralateral kidneys of rats with UUO,
COL IV was observed very clearly in the TBM, Bowman's
capsules, peritubular capillaries and in the mesangium. There
was little COL IV in the interstitial space (Fig. 4A). The amount
of COL IV in the contralateral kidney did not change at three or
five days of UUO as compared to that of the control kidney.
The obstructed kidney showed an increased deposition of COL
IV at three days. There was thickening of the TBM and a
widened interstitial space of the renal cortex. The increase was
more prominent at five days (Fig. 4B). Increased deposition of
COL IV was observed mainly in basement membranes, Bow-
man's capsules and peritubular capillaries. However, it was
diffusely increased in the interstitial space where the deposition
was prominent. The increase of COL IV was found in the whole
area of the renal cortex of the obstructed kidney at day 5,
although the increase was not homogeneously observed. Gb-
meruli did not show any change in COL IV deposition in either
the contralateral or the obstructed kidney.
COL III was faintly stained and was confined to the renal
interstitial space and the mesangium. It was not detected in the
TBM in the control and contralateral kidneys (Fig. 4C). In the
obstructed kidney COL III was obviously increased in the
interstitial space surrounding tubules and capillaries and formed
a fine network in the interstitium although the intensity of
immunostaining was still low (Fig. 4D).
COL I was well stained when the kidney was fixed with
Histochoice but not with 4% paraformaldehyde. COL I, similar
to COL III, was restricted to the interstitium but the amount of
COL I was less than that of COL III in the control and
contralateral kidneys (Fig. 4E). In the obstructed kidney COL I
increased remarkably in the interstitial space (Fig. 4F). Funda-
mentally COL I was not increased in TBM of the obstructed
kidney, although the thickened COL I fibers enclosed the renal
tubules giving the appearance of a thickened TBM. COL I and
COL III were faintly observed in the glomeruli in the control
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Fig. 4. Immunofluorescent micrographs of contralateral and obstructed kidneys at 5 days of UUO, stained for COL IV (A and B, respectively),
COL III (C and D, respectively) and COL I (E and F, respectively). Sections fixed with 4% paraformaldehyde were used for COL IV and III and
a Histochoice-fixed specimen was used for COL I. Magnification: x400.
Group N
Matrix score
0 1 2 3
Untreated 3 0 8.9 4.4 40.2 8.5 50.9 10.6
Enalapril 5 2.3 1.9 24.8 75a 535 4.2a 22.0 8•1b
The relative frequency of matrix score was obtained from over 100
different fields of each separate kidney. Values are means SD (%) of
relative frequency at each matrix score point. The mean scores of the
control and contralateral kidneys were near 0 in every rat.
a P < 0.05 and bp < 0.01 when compared to the relative frequency
of untreated rats at the same matrix score point
and the contralateral kidneys. However, glomeruli did not show
any increase of these proteins during UUO.
Matrix deposition score of COL IV
We determined the matrix deposition score of COL IV from
o to 3 in order to assess whether enalapnl treatment affected the
increased deposition of COL IV in the obstructed kidney at five
days of UUO. The mean score of the control and contralateral
kidneys was near 0 in every rat (data not shown). The relative
frequency of each score point was obtained from over 100
different fields of each kidney (Table 1). The untreated rats
showed a higher frequency at point 3 and a lower frequency at
points 0 and 1. However, in the enalapril treated rats the
frequency of points 1 and 2 increased significantly and that of
point 3 decreased significantly when compared to the data for
the untreated rats. Figure 5 illustrates the mean matrix score of
each group. The mean score of the untreated rats (2.4 0.1)
was slightly but significantly (P < 0.01) decreased, to 1.9 0.2,
by enalapril treatment although the score was still high after
treatment when compared to the score of control kidneys or
contralateral kidney of rats with UUO.
Immunoblotting of CNBr peptides against COL IV
The immunoblot depicted in Figure 6 shows several CNBr
peptides from COL IV in the cortex at five days of UUO.
Collagen proteins were cleaved into several smaller weight
peptides by CNBr. Peptides of 84 kDa and 73 kDa were
immunogenic against the COL IV antisera used. These CNBr
peptides were obviously increased in the renal cortex of the
obstructed kidneys compared to the control and the contralat-
eral kidneys. The amount of COL IV peptides in the cortex of
the obstructed kidney was slightly decreased by enalapril.
Table 1. Matrix deposition score of COL IV in the obstructed kidney
in rats with UUO of 5 days duration
P<0.013
2
0
C)(0
0
Untr EnI
Fig. 5. Mean matrix deposition score of COL IV from the obstructed
kidney of untreated (UNTR, N = 3) and enalapril (ENL, N 5)
untreated rats. The bar represents mean SD.
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Fig. 6. Immunoblotting of CNBrpeptides against COL lv in the cortex
at 5 days of UUO. Twenty micrograms of CNBr peptides was applied
to each lane. Numbers represent molecular weights of pre-stained
molecular standards. Abbreviations are: UNTR, untreated; ENL,
enalapril; S, sham-operated kidney; C, contralateral kidney; 0, ob-
structed kidney,
C 0 M C 0
Collagen
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Densitometric analysis revealed an approximate 20% decrease
in the amount of CNBr peptides in the obstructed kidney of rats
treated with enalapril.
mRNA expression of collagen al(IV) during UUO
Figure 7A demonstrates the PCR products of collagen a(IV)
and GAPDH at three or five days of UUO. A PCR product for
collagen al(IV) showed a very faint band or was not detectable
in the contralateral kidney at every time point. The obstructed
kidney showed a prominent increase of mRNA level at three
days and the level was still high at five days of UUO. The
GAPDH PCR products were prominent and not significantly
different in renal cortex of sham, contralateral or obstructed
kidneys. We measured mRNA expression of collagen al(IV) in
isolated glomeruli and tubules from the kidney after five days of
UUO to determine the region of the nephron in which the
matrix protein mRNA might be increased (Fig. 7B). We found
that the mRNA of collagen al(IV) was abundant in glomeruli of
the contralateral kidney and that the mRNA level did not
change in the glomeruli of obstructed kidney during UUO.
However, the renal tubules showed a prominent increase of
mRNA expression in the obstructed kidney while mRNA
expression was very low or undetectable in the contralateral
kidney. Figure 8 demonstrates the relative level of mRNA
expression of collagen al(IV) in the obstructed kidney at three
or five days of UUO. The amount of mRNA of the contralateral
kidney was essentially undetectable (data not shown). The
obstructed kidney showed a remarkable increase in mRNA
expression at either three or five days of UUO. The increased
mRNA level of collagen al(IV) present in the obstructed kidney
Fig. 7. mRNA expression of collagen al(IV) in the cortex (A) at 3 or 5
days and in the glomeruli and tubules (B) at 5 days of UUO. Abbrevi-
ations are: C, contralaterai kidney; 0, obstructed kidney; M, DNA
standard marker; G, glomeruli; T, tubules.
was significantly (P < 0.01) blunted (42%) but not completely
suppressed by enalapril treatment at five days, while it was not
affected at three days of UUO.
We previously showed that TGF-/31 mRNA increased in
renal cortical tubules rather than in the glomeruli obtained from
the obstructed kidney at five days of UUO [8]. In the present
study we measured the expression of collagen a(IV) and
TGF-f31 in the renal tubules from rats with or without enalapril
treatment. This was to determine whether the increase in
mRNAs present in the tubules of the obstructed kidney was
suppressed by enalapnl. PCR amplification was performed
using 2 tg of RNA and 30 cycles for TGF-J31 as described
previously [8]. Figure 9 demonstrates PCR products from two
different experimental animals following five days of UUO. In
the untreated rats both collagen al(IV) and TGF-/3l mRNAs
were increased in the obstructed kidneys when compared to the
contralateral kidneys. In contrast, in the enalapnl-treated rats
collagen a(IV) mRNA was undetectable in the obstructed
UNTR
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kidneys and TGF-j31 mRNA was suppressed both in the con-
tralateral and obstructed kidneys.
Blood pressure
Enalapril-treated rats showed significantly (P < 0.01, un-
paired t-test with Welch's correction, N = 3) lower MAP than
untreated rats at three days and five days of UUO (110 1 vs.
121 2, 100 1 vs. 124 2, respectively). Mean arterial
pressures of untreated rats at three days and five days of UUO
were not different from those of control rats (121 1).
Infiltration of the kidney by monocytesimacrophages during
UUo
As has been reported previously [21], there is an infiltration
of the renal cortex by ED-i positive monocytes/macrophages
(Fig. bA). The infiltrate at day 5 of UUO is larger than that
previously reported at day 2 of UUO [21]. In contrast, enaiapril
pretreatment and cotreatment of the animals resulted in a
significant reduction in the number of infiltrating ED-i positive
cells (Fig. lOB and Table 2). There was no significant infiltrate
of ED-i positive cells in the contralateral kidney of rats with
UUO compared to the kidney of normal rats (not shown).
Enalapril treatment had no discernible effect on the monocyte!
macrophage content of the contralateral kidney.
Discussion
Nagei and Bulger [1] reported that in the obstructed kidney of
rabbits the interstitial space was widened and interstitial fibrosis
was present at seven days after UUO. We found that after three
days of UUO the relative volume of the cortical interstitium is
increased significantly in the obstructed kidney of the rat. The
deposition of COL I, COL III and COL IV also increased in the
tubulointerstitium by the third day of UUO. Furthermore, the
mRNA level of collagen al(IV) was significantly elevated in the
obstructed kidney at this time point. Thus, interstitial fibrosis is
initiated promptly after the onset of obstruction. We demon-
strated by immunofluorescence studies that the amount of COL
I, COL III and COL IV in the glomeruli of the obstructed
kidney was not changed at 5 days of UUO. Our previous study
showed that TGF-f3l rnRNA levels did not change in the
glomeruli of the obstructed kidney during UUO [8]. These data
are consistent with the fact that glomeruli appeared normal by
light microscopy through 7 days of obstructive nephropathy
[22, 23]. The localization of interstitial COL I and COL III in
the glomeruli of the normal kidney is controversial [24—27].
However, we found COL I and COL III in the glomeruli of our
specimens of rat kidneys when fixed with Histochoice and when
the sections were treated with trypsin to uncover these
epitopes.
We also found that both the interstitial collagen (types I and
III) and the basement membrane collagen (type IV) were
deposited in the interstitial space of the obstructed kidney. In
the obstructed kidney both COL I and COL III were increased
in the interstitial space only, while COL IV was deposited both
in TBM and the interstitium of the obstructed kidney. Haralam-
bous-Gasser et al [28] quantitated collagen by CNBr peptide
analysis in the whole kidney of newborn rats with incomplete
UUO. They showed that over 50% of the collagen in the normal
kidney was COL I and COL III and these appeared to be major
collagens that were increased in the obstructed kidney of
newborn rats. Our immunofluorescence studies demonstrated
that COL IV is a major collagen that was increased in the renal
cortex of adult rats during UUO. The increase in COL IV in
both TBM and interstitial space may contribute to the dysfunc-
tion of renal tubules of the obstructed kidney. Thus, we focused
mainly on collagen IV as a global indicator of fibrosis within the
kidney even though the effects of other TBM or ECM proteins
in the setting of obstructive nephropathy may be considerable.
Jones et al [24] showed that during purine aminonucleoside
nephrosis COL IV increased in both TBM and the interstitium;
COL I and COL III levels increased but were confined to the
interstitium. Downer, Phan and Wiggins [25] reported that in a
model of crescentic nephritis in the rabbit COL IV was local-
ized to glomeruli and the periglomerular area while COL I and
COL III were present in both the glomeruli and the interstitium.
The meaning of the difference of deposition patterns between
COL I/Ill and COL IV is not clear. Intrinsic differences related
to the renal injuries may be partially explanatory. It should be
noted that there is a monocyte/niacrophage influx into the
glomeruli of aminonucleoside nephrosis [24, 29] that is absent
from glomeruli of obstructed kidneys [21].
Cultured renal tubular cells produce collagen types I, III and
IV [30, 31]. We found that the expression of collagen al(IV)
mRNA was remarkably increased in the tubules of the ob-
structed kidney. Thus, it is conceivable that renal tubules
contribute to the increased production of COL IV and the
increased deposition of COL IV in both TBM and interstitium.
Nagel and Bulger have reported that fibroblasts migrated and
proliferated in the interstitium of the obstructed kidney during
UUO [1] and that interstitial fibroblasts produce COL I, III and
IV [3]. Kuncio, Neilson and Haverty have observed that
several cytokines secreted by infiltrating macrophages and
T-lymphocytes act as chemoattractants and stimulate fibroblast
proliferation [3]. The remarkable increase in COL I and COL
III that we found in the interstitium of the obstructed kidney at
three or five days of UUO is consistent with the increased
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respectively. ENL: N = 7 at 3 or 5 days.
Untr Eni Untr Eni
-— — S —
a.
1644 Kaneto et al: Enalapril reduces interstitial fibrosis
UNTR
II
ENL
I H
C 0 C 0 C 0 C 0
Collagen
al (IV)
TGFI31
GAPDH
cellularity due to fibroblast proliferation and infiltrating mono-
nuclear cells. Thus, the interstitial fibroblasts may also contrib-
ute to an increase in production of collagens in the obstructed
kidney in UUO.
We reported previously that TGF-131 mRNA expression
increased in the obstructed kidney and that this increase was
found in renal tubular cells rather than glomeruli [8]. TOF-/31
has pleiotropic effects on matrix protein production [32]. These
include an increase in the mRNA of ECM components, partic-
ularly the collagens [3, 32], a decrease in proteases degrading
these proteins and an increase in metalloprotease inhibitors.
Our studies suggest that the increase in TGF-pl in the cortical
tubules of the obstructed kidney results in an increase of
collagen al(IV) mRNA. The increase in collagen IV protein is
undoubtedly due to the increase in the mRNA. Although we did
not measure proteases or proteases inhibitors, they may also
have a role in the fibrosis of ureteral obstruction.
We found that enalapril treatment significantly blunted the
increased volume of the interstitium present in the obstructed
kidney at either three or five days of UUO. Enalapril curtailed
the increased amount of COL IV in the obstructed kidney as
assessed by the matrix deposition score (Table 1) and by
immunoblotting of CNBr peptides of the whole renal cortex
(Fig. 6). The increase in collagen al(IV) niRNA level was
significantly blunted by enalapril at five days but not at three
days of UUO. Thus, the decrease of COL IV deposition might
be due to the decrease of niRNA expression in renal cortex
although this would not account for the reduction in relative
volume of the interstitium at three days. It may be that other
types of collagen or other extracellular matrix components are
decreased by enalapril. Enalapril might also affect the balance
between production and degradation of ECM proteins. Enala-
pril was found to significantly decrease the number of infiltrat-
ing ED-I positive monocytes/macrophages into the interstitium.
This would decrease the cellularity within the interstitium and
contribute, in part, to the blunted volume increase of this
compartment. Effects of enalapril on fibroblast proliferation
remain to be determined.
The dosage of enalapril we injected intrapentonealy is essen-
tially equivalent to 200mg/liter in drinking water based upon the
Fig. 9. Effects of enalapril on mRNA
expression of collagen al(IV) and TGF-f31 in
the renal cortical tubules after 5 days of
UUO. Results are from two different
experimental animals of untreated (UNTR) or
enalapril-treated (ENL) group. Abbreviations
are: C, contralateral kidney; 0, obstructed
kidney.
average water consumption by the rat in a 24-hour period. This
is higher than the dose (50 mg/liter drinking water) used by
others [33]. Ikomaet al [34] showed a greater effect of low dose
(50 mg/liter) than high dose (200 mg/liter) ACE! on structure-
preservation in a nephrectomy model. They suggested that the
low dose of enalapril blocked endothelial ACE and the high
dose of ACE! blocked endogenous ACE in kidney. We previ-
ously showed that prior inhibition of ACE by enalapril (5 mg/kg
body wt twice a day) ameliorated the decreased renal function
present in the obstructed kidney [35] and suppressed endoge-
nous angiotensin production during ureteral obstruction [36].
We showed that the high dose of enalapril used in the present
study reduced MAP of UUO rats to a significantly lower level
as compared to that of control rats and that enalapril amelio-
rated interstitial fibrosis present in the obstructed kidney.
However, there is some evidence that ACE! has greater pro-
tective effects on progressive renal injury than triple therapy
(reserpine, hydralazine and hydrochlorothiazide) although both
therapies normalized systemic hypertension [33]. Further,
Kakinuma et al [37] reported that ACE!, not triple therapy,
ameliorated vascular lesions of chronic renal failure although
both ACE! and triple therapy suppressed the increased blood
pressure of nephrectomized rats. In this latter study [37], twice
as much enalapril was used as in the present study.
The renin-angiotensin system is activated after ureteral ob-
struction [38]. In addition, angiotensin II stimulates transcrip-
tion and synthesis of COL IV in cultured proximal tubular cells
[39] and rats infused with angiotensin II develop interstitial
fibrosis with an increased COL IV deposition [40]. Renal
proximal tubular cells have an active renin-angiotensin operat-
ing system [41] while tubular cells produce and secrete angio-
tensin II into the intratubular fluid [42]. We demonstrated that
the expression of collagen al(IV) mRNA was increased in the
renal tubules and this increase was abrogated by enalapnl. The
increase in TGF-j31 mRNA level present in the obstructed
kidney was also suppressed by enalapril (Fig. 9), as was the
monocyte/macrophage infiltration (Fig. 10). Angiotensin II,
therefore, may contribute to the increased production of COL
IV and to a possible chemoattractant to monocytes/macro-
phages in the obstructed kidney during UUO. The stimulating
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Fig. 10. Effect of enalapril on the ED-I
positive cell infiltrate in ureteral obstructed
rat kidney. Depicted are representative
photomicrographs of cortex of untreated (A)
and enalapril treated (B) animals.
Table 2. Effect of enalapril treatment on the monocyte/macrophage
infiltrate of the kidneys of rats with UUO of 5 days duration
Group
Condition
Obstructed kidney Contralateral kidney
Untreated 60.2 5.1k 2.9 0.2
Enalapril treated 6.8 1.5 2.5 0.5
Values are means SD of the number of ED-i positive cells per 200 x
field of kidney cortex of 3 Separate animals.
a P < 0.001 by ANOVA of untreated versus treated obstructed
kidney
effects of angiotensin II on COL IV production in the renal
tubules may be mediated by an increase in TGF-/31. However,
the increased deposition and expression of collagen IV mRNA
in the renal cortex were not completely abrogated by enalapril
administration. While enalapnl effectively reduced the mono-
cyte/macrophage infiltrate within the renal cortex it did not as
effectively reduce TGF-f31 mRNA expression [8]. Intrinsic
kidney tubular cells probably account, in part, for the increased
TGF-f31 mRNA expression due to UUO. The monocyte/mac-
rophage infiltrate may account for the remainder of the TGF-f31
mRNA expression. Thus, other mechanisms probably contrib-
ute to the initiation and progression of interstitial fibrosis during
obstructive nephropathy.
In summary, we demonstrated that the relative volume of the
tubulointerstitium was significantly increased in the renal cor-
tex of the affected kidney at three days or five days of UUO
when compared to the control and contralateral kidneys. This
increase was due to an increase in the deposition of both
interstitial collagens (types I and III) and basement membrane
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collagen (type IV). The amount of protein and expression of
COL IV mRNA were increased in the obstructed kidney.
Enalapnl blunted the increase in the interstitial volume, COL
IV deposition and COL IV mRNA present in the renal cortex of
the obstructed kidney. These results indicate that enalapril
substantially ameliorates the tubulointerstitial fibrosis of the
affected kidney in UUO. The mechanism by which enalapril
retards or inhibits fibrosis may be through a substantial de-
crease in the number of infiltrating monocytes/macrophages in
the UUO kidney. This may contribute, in part, to the decrease
in TGF-/31 mRNA expression and eventual profibrotic effect of
this factor.
No reprints are available. Correspondence to Saulo Klahr, M.D.,
Department of Medicine, The Jewish Hospital of St. Louis, 215 South
Kingshighway, St. Louis, Missouri 63110, USA.
References
1. NAGEL RB, BULGER RE: Unilateral obstructive nephropathy in the
rabbit. II. Late morphologic changes. Lab Invest 38:270—278, 1978
2. SHARMA AK, MAUER SM, KIM Y, MICHAEL AF: Interstitial
fibrosis in obstructive nephropathy. Kidney mt 44:774—788, 1993
3. KUNCIO GS, NEILSON EG, HAVERTY T: Mechanisms of tubuloin-
terstitial fibrosis. Kidney mt 39:550—556, 1991
4. STERZEL RB, SCHULZE-LOHOFF E, WEBER M, GOODMAN SL:
Interactions between glomerular mesangial cells, cytokines, and
extracellular matrix. JAm Soc Nephrol 2:S 126—S131, 1992
5. ROBERTS AB, MCCUNE BK, SPORN MB: TGF-/3: Regulation of
extracellular matrix. Kidney mt 41:557—559, 1992
6. BORN5TEIN P, SAGE H: Regulation of collagen gene expression.
Progr Nucl Acid Res Mo! Biol 37:67—106, 1989
7. NAKAMURA T, MILLER D, RUOSLAHTI E, BORDER WA: Production
of extracellular matrix by glomerular epithelial cells is regulated by
transforming growth factor-/31. Kidney mt 41:1313—1221, 1992
8. KANETO H, MORRISSEY J, KLAHR S: Increased expression of
TGF-/3 niRNA in the obstructed kidney of rats with unilateral
ureteral ligation. Kidney Int 44:313—321, 1993
9. BRUNNER FP, THIEL 0, HERMLE M, BOCK HA, MIHATSCH MJ:
Long-term enalapril and verapamil in rats with reduced renal mass.
Kidney mt 36:969—977, 1989
10. IKOMA M, KAWAMURA T, KAKINTJMA Y, FoGo A, ICHIKAWA I:
Cause of variable therapeutic efficiency of angiotensin converting
enzyme inhibitor on glomerular lesions. Kidney mt 40: 195—202,
1991
11. Dwoniu LD, BENSTEINJA, PARKERM, TOLBERTE, FEINERHD:
Calcium antagonists and converting enzyme inhibitors reduce renal
injury by different mechanisms. Kidney mt 43:808—814, 1993
12. LAFAYETFE RA, MAYER 0, MEYER TW: The effects of blood
pressure reduction on cyclosporine nephrotoxicity in the rat. JAm
Soc Nephrol 3:1892—1899, 1993
13. DIAMOND JR, ANDERSON S: Irreversible tubulointerstitial damage
associated with chronic aminonucleoside nephrosis. Amelioration
by angiotensin I converting enzyme inhibition. Am J Pathol 137:
1323—1332, 1990
14. NORMAN JT, GALLEGO C, BRIDGEMAN DA, FoGo A, FINE LG:
Enalapril ameliorates interstitial fibrosis in the remnant kidney of
the rat. (abstract) JAm Soc Nephrol 3:746, 1992
15. MØLLER JC, SKRIvER E: Quantitative ultrastructure of human
proximal tubules and cortical interstitium in chronic renal disease
(hydronephrosis). Virchows Arch A Pathol Anat Histopathol 406:
389—406, 1985
16. BELLON G: Quantification and specific detection of collagenous
proteins using an enzyme-linked immunosorbent assay and an
immunoblotting for cyanogen bromide peptides. Anal Biochem
150:188—202, 1985
17. EPSTEIN EH: [aI(III)]3 human skin collagen. Release by pepsin
digestion and preponderance in fetal life. J Biol Chem 249:3225—
3231, 1974
18. CHOMCZYNSKI F, SACCHI N: Single-step method of RNA isolation
by acid guanidinium thiocyanate-phenol-chloroform extraction.
Anal Biochem 162:156—159, 1987
19. Rocco VM, NEILSON EG, HOYER JR, ZIYADEH FN: Attenuated
expression of epithelial cell adhesion molecules in murine polycys-
tic disease. Am J Physiol 262:F679—F686, 1992
20. FORT P, MARTY L, PIECHACZYK M, SABROUTY SE, DANI C,
JEANTEUR P, BLANCHARD JM: Various rat adult tissues express
only one major mRNA species from the glyceraldehyde-3-phos-
phate-dehydrogenase multigenic family. Nucleic Acids Res 13:
1431—1442, 1985
21. SCHREINER G, HARRIS K, PURKERSON M, KLAHR S: Immunologi-
cal aspects of acute ureteral obstruction: Immune cell infiltrate in
the kidney. Kidney Int 34:487—493, 1988
22. REYES AA, KA1u. IE, KISSANE J, KLAHR S: L-arginine administra-
tion prevents glomerular hyperfiltration and decreases proteinuria
in diabetic rats. JAm Soc Nephrol 4:1039—1045, 1993
23. NAGEL RB, BULGER RE, CU1-I-ER RE, JERVIS HR, BENDITT EP:
Unilateral obstructive nephropathy in the rabbit. I. Early morpho-
logic, physiologic, and histochemical changes. Lab Invest 28:456—
467, 1973
24. JONES CL, BUCH S, POST M, MCCULLOCH L, Lw E, EDDY AA:
Pathogenesis of interstitial fibrosis in chronic purine aminonucleo-
side nephrosis. Kidney mt 40: 1020-1031, 1991
25. DOWNER G, PHAN SH, WIGGINS RC: Analysis of renal fibrosis in a
rabbit model of crescentic nephritis. J Clin invest 82:998—1006, 1988
26. FLOEGE J, JOHNSON RI, GoitnoN K, YOSHIMURA A, CAMPBELL C,
IRUELA-ARISPE L, ALPERS CE, CousER WG: Altered glomerular
extracellular matrix synthesis in experimental membranous ne-
phropathy. Kidney in! 42:573—585, 1992
27. YOSHIOKA K, TAKEMURA T, T0HDA M, AKANO N, MIYAMOTO H,
O05HIMA A, MAKI S: Glomerular localization of type III collagen in
human kidney disease. Kidney In! 35: 1203—1211, 1989
28. HARALAMBOUS-GASSER A, CHAN D, WALKER RG, POWELL HR.
BECKER GH, JONES CL: Collagen studies in newborn rat kidneys
with incomplete ureteric obstruction. Kidney mt 44:593—605, 1993
29. DIAMOND J, PE5EK-DIAMOND I: Sublethal x-irradiation during
acute puromycin nephrosis prevents late renal injury: Role of
macrophages. Am J Physiol 260:F779—F786, 1991
30. HAVERTY TP, KELLY CJ, HINES WH, AMENTA PS, WATANABE M,
HARPER RA, KEFALIDES NA, NEILSON EG: Characterization of a
renal tubular epithelial cell line which secretes the autologous target
antigen of autoimmune experimental interstitial nephritis. J Cell
Biol 107:1359—1368, 1988
31. CREELY JJ, COMMERS PA, HARALSON MA: Synthesis of type III
collagen by cultured kidney epithelial cells. Connect Tissue Res
18: 107—122, 1988
32. ROBERTS AB, MCCUNE BK, SP0RN MB: TGF-/3: Regulation of
extracellular matrix. Kidney In! 41:557—559, 1992
33. ANDERSON 5, RENNKE HG, BRENNER BM: Therapeutic advantage
of converting enzyme inhibitors in arresting progressive renal
disease associated with systemic hypertension in the rat. J Clin
Invest 77:1993—2000, 1986
34. IKOMA M, KAWAMURA T, KAKINUMA Y, FoGo A, ICHIKAWA I:
Cause of variable therapeutic efficiency of angiotensin converting
enzyme inhibitor on glomerular lesions. Kidney mt 40:195—202,
1991
35. PURKERSON ML, KLAHR 5: Prior inhibition of vasoconstrictors
normalizes GFR in postobstructed kidneys. Kidney In! 35:1306—
1314, 1989
36. YANAGISAWA H, MORRISSEY J, MORRISON AR, KLAHR 5: Ei-
cosanoid production by isolated glomeruli of rats with unilateral
ureteral obstruction. Kidney mt 37:1528—1535, 1990
37. KAKINUMA Y, KAWAMURA T, BILLS T, YOSHIOKA T, ICHIKAWA I,
Fooo A: Blood pressure-independent effect of angiotensin inhibi-
tion on vascular lesions of chronic renal failure. Kidney mnt 42:46—
55, 1992
38. EL-DAItR SS, GEE J, DiP S, HANSS BG, VARI RC, CHAO J:
Kaneto eta!: Enalapri! reduces interstitial fibrosis 1647
Upregulation of renin-angiotensin system and downregulation of
kallikrein in obstructive nephropathy. Am J Physiol 264:F874—
F881, 1993
39. WOLF G, KILLEN PD, NEILSON EG: Intracellular signaling of
transcription and secretion of type IV collagen alter angiotensin
11-induced cellular hypertrophy in cultured proximal tubular cells.
Mo! Biol Cell 2:219—227, 1991
40. JOHNSON RJ, ALPERS CE, YOSHIMtJRA A, LOMBARD! D, PRITZL P,
FLOEGE J, SCHWARTZ SM: Renal injury from angiotensin II-
mediated hypertension. Hypertension 19:464—474, 1992
41. WOLF G, NEILSON EG: Angiotensin II as a hypertrophogenic
cytokine for proximal tubular cells. Kidney mt 43 (Suppl 39):S100—
S107, 1993
42. BRAAM B, METCHELL KD, Fox J, NAVAR LG: Proximal tubular
secretion of angiotensin II in rats. Am J Physiol 264:F89l—F898,
1993
